MyCycleClarity
Commercial- Indications
- Fertility monitoring
Company intelligence / Profile preview
Cycle Clarity has developed and commercialized an FDA-cleared artificial intelligence platform that automates and standardizes ovarian follicle measurements from ultrasound images, improving accuracy, reproducibility, and efficiency in fertility care. The technology enables remote review of encrypted ovarian and uterine videos by reproductive endocrinologists, supports collaborative care between OB/GYNs and fertility specialists, and aims to set a new global standard for monitoring ovarian stimulation in infertility treatment. Clinical results indicate the software provides high accuracy in follicle identification—trained on over 90,000 annotated follicles—and has been described as disruptive by clinicians for its impact on patient convenience, clinical efficiency, and measurement precision.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cycle Clarity.